ArticleScientific reports2020

Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.

Maria Del Carmen Asensio Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.